Dermira, Inc., a biopharmaceutical company, engages in identifying, developing, and commercializing therapies to enhance the lives of patients with dermatologic diseases primarily in the United States. The company has market cap of $1.19 billion. The companyÂ’s late-stage product candidates include Cimzia, an injectable biologic tumor necrosis factor-alpha inhibitor to treat various inflammatory diseases, as well as to treat patients with moderate-to-severe chronic plaque psoriasis; Glycopyrronium tosylate, a small-molecule anticholinergic product that is in Phase III clinical trial for the treatment of primary axillary hyperhidrosis or excessive underarm sweating; and Olumacostat glasaretil, a small-molecule sebum inhibitor, which is in Phase III clinical trial to treat acne vulgaris or acne. It currently has negative earnings. It has a collaboration agreement with UCB Pharma S.A. for the development and commercialization of Cimzia.
Sypris Solutions, Inc. (SYPR) formed wedge down with $1.46 target or 3.00% below today’s $1.50 share price. Sypris Solutions, Inc. (SYPR) has $31.94M valuation. The stock increased 0.67% or $0.01 during the last trading session, reaching $1.5. About 6,488 shares traded. Sypris Solutions, Inc. (NASDAQ:SYPR) has risen 46.53% since January 12, 2017 and is uptrending. It has outperformed by 29.83% the S&P500.
Investors sentiment is 0.88 in Q3 2017. Its the same as in 2017Q2. It is without change, as 3 investors sold Sypris Solutions, Inc. shares while 5 reduced holdings. only 2 funds opened positions while 5 raised stakes. 3.01 million shares or 0.05% less from 3.01 million shares in 2017Q2 were reported. Blackrock has 38,153 shares for 0% of their portfolio. Bridgeway Capital Mgmt holds 46,404 shares. Vanguard Group reported 185,235 shares or 0% of all its holdings. California Pub Employees Retirement invested in 0% or 49,748 shares. Deutsche Retail Bank Ag invested in 47,041 shares. Moreover, State Bank Of Ny Mellon Corporation has 0% invested in Sypris Solutions, Inc. (NASDAQ:SYPR). Northern Trust Corporation reported 27,482 shares or 0% of all its holdings. Geode Management Limited Liability Company reported 50,846 shares. Needham Investment Mngmt Limited Liability Company reported 0.03% in Sypris Solutions, Inc. (NASDAQ:SYPR). Citadel Limited Liability Co reported 11,646 shares or 0% of all its holdings. Thompson Davis And Company, a Virginia-based fund reported 4,000 shares. Wells Fargo & Company Mn owns 1 shares for 0% of their portfolio. Renaissance Tech Limited Liability Company accumulated 620,841 shares. Royal Commercial Bank Of Canada invested 0% of its portfolio in Sypris Solutions, Inc. (NASDAQ:SYPR). Tower Cap Llc (Trc) has 8,060 shares.
The stock increased 7.19% or $1.92 during the last trading session, reaching $28.62. About 241,031 shares traded. Dermira, Inc. (DERM) has declined 7.44% since January 12, 2017 and is downtrending. It has underperformed by 24.14% the S&P500.
Since January 1, 0001, it had 0 insider buys, and 12 insider sales for $1.50 million activity.